In this episode of DeviceTalks, we catch up with LifeScience Alley CEO Shaye Mandle about doing business in Minnesota’s world class medical device cluster. We delve into why the medical device and life sciences community clustered in the Twin Cities, what new trends in funding, M&A and technology are developing in the area and, of […]
Rotator cuff disease is one of the most common injuries in the world, with more than 3 million in the U.S. alone suffering damage to the tissues connecting muscle to bone in the shoulder. But the standard treatment for rotator cuff disease is clunky, painful and often inefficient, with an estimated 40% of patients experiencing re-tearing of […]
Tal Medical‘s roots go back to a serendipitous discovery at McLean Hospital more than a decade ago, when researchers working on bi-polar disorder reported that patients said they felt better after receiving an MRI. As it often does in medtech, that initial moment of discovery paved the way for years of development, eventually leading to […]
Fred Lampropoulos’ life reads like something out of a Horatio Alger novel. Lampropoulos, 65, started South Jordan, Utah-based medical device company Merit Medical Systems (NSDQ:MMSI) in 1987 and has grown it to more than $500 million in annual sales. He also served in the Special Forces (Airborne), ran for public office twice in Utah and opened […]
By Stewart Eisenhart, Emergo Group Brazil’s medical device market offers significant growth potential for foreign manufacturers, but the country’s device approval process is challenging. In this podcast, Emergo Vice President of Business Development Ann Marie Boullie provides an overview of Brazil’s regulatory requirements for medical device registration, including:
By Stewart Eisenhart, Emergo Group Medical device manufacturers thinking about market authorization pathways in Canada can learn more about the process via this Emergo podcast. Emergo Managing Director for Canada Daryl Wisdahl explains key issues related to Canadian regulatory requirements for medical devices, including:
Caroll Neubauer is a man of strong opinions.
Fortunately for us, the chairman & CEO of 175-year-old German medical products conglomerate B. Braun Medical isn’t afraid to share those opinions – even though he admits that they occaisionally get him into trouble. A case in point, as you’ll hear in this podcast, is Neubauer’s passionate opposition to the medical device excise tax.
On July 15, 2014, MassDevice.com brought together 4 senior medtech leaders to discuss the future of the medical device industry at our DeviceTalks Boston event.
More than a year ago, Haemonetics (NYSE:HAE) launched a major restructuring effort, moving nearly 300 manufacturing jobs out of the country in an effort to cut between $35 million and $40 million by fiscal 2018.
The cuts were painful, not only for the 42-year-old blood management company and its workers, but for CEO Brian Concannon, who grew up only a stone’s throw from the company’s headquarters in Braintree, Mass.